Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
about
Strategies for early detection of resectable pancreatic cancerIdentification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresisApolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trialHuman body fluid proteome analysis.Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.Advanced proteomic technologies for cancer biomarker discovery.Feature detection techniques for preprocessing proteomic data.Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2.Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.Proteomic analysis of urinary upper gastrointestinal cancer markers.Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.Immunoaffinity chromatography: an introduction to applications and recent developments.Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases.Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.Comparative serum proteome expression of the steroid-induced femoral head osteonecrosis in adultsDetection of pancreatic cancer using serum protein profiling.The current state of proteomics in GI oncology.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Proteomic technology for biomarker profiling in cancer: an updateChemically induced breast tumors in rats are detectable in early stages by contrast enhanced magnetic resonance imaging but not by changes in the acute-phase reactants in serumProteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph.Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.Proteomic profiling of the mesenteric lymph after hemorrhagic shock: Differential gel electrophoresis and mass spectrometry analysis.Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded studySerum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.Proteomics analysis of bodily fluids in pancreatic cancerAdvances in biomarker research for pancreatic cancer.Identifying molecular markers for the early detection of pancreatic neoplasia.Ductal pancreatic cancer in humans and mice.Proteomics studies of pancreatic cancerProtein expression profiles of human lymph and plasma mapped by 2D-DIGE and 1D SDS-PAGE coupled with nanoLC-ESI-MS/MS bottom-up proteomicsStable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.State of the art in tumor antigen and biomarker discovery.Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinomaMass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Proteomic sample preparation for blast wound characterization.
P2860
Q24564006-4B6A1948-CEC9-45F1-A89B-4B1A74C931C8Q24600418-C3F88A88-E2AB-4169-9B6B-7EFA5B46FB63Q28383260-3A9DCD2F-B9F8-4E49-A144-A75ACB3084DEQ33262623-DEA02AA6-007A-48B4-8C45-FED7AA9ABA3CQ33290708-A592A5B4-4AA6-4044-BC4F-41DBF5E59543Q33307131-F8E84A2A-986D-4347-914D-0A3620431BADQ33433660-873A6F4C-EC60-4F3A-B392-D0F23A872B25Q33577873-C21B218D-AC75-4987-8030-94D8C2E1DD1FQ33619820-5A457EB7-C517-4F5A-9359-3CA9730F22CCQ33805149-E7808FA1-4871-4CFC-994E-A07C69CAE760Q33888474-07750711-2CAC-450D-A8B4-40EAC15B850BQ33945104-6A7BF294-2ABC-4197-AB70-B0B4C206E347Q33992933-209963AA-B306-457C-992B-6FE7E5D38153Q34030497-D7FDE86E-D511-43D9-9732-DDA40E3843D2Q34073892-F622B6A2-2551-4F87-8C7B-EE3BAFD89DC3Q34173955-0F74E6DA-12D2-48A0-A571-1B9DE94FE82CQ34585357-8F6179AE-7A0F-4CFB-A7E1-DC267FCE68E4Q34607497-2D95F58E-2257-45B8-BA4B-2A7DC869B3A4Q34608851-3583D90C-2C40-47AF-89CA-13DF05B82865Q34644418-E0EC92E3-C55B-4067-82D1-17B8A7E36DFFQ34657835-C9CBFAEF-5AAE-4F09-9D26-3D0EB04B5777Q34874859-126A116B-6CC1-4365-AA9B-3C0A95DCF68FQ35038127-D58663B5-C177-40BD-9AFD-01AA37D2CBB1Q35070494-5DE32083-4C54-4A98-814F-5CE5DCE250EAQ35109507-105BF597-7BBB-451B-BDAE-EABB1B97D6FDQ35196988-E3AE50FB-46FE-493C-BB6C-71D8FF44AA8BQ35208879-4934803B-7CDF-4162-B1E8-364B2365A2C5Q35266857-FD7B64C9-BE38-46E0-B007-6F4A83F2B96BQ35798915-CB03AAB2-3A81-4635-9972-825E9345D889Q35920900-B0BAF81D-A35B-480A-A04A-F07133480473Q36126609-F8AFE57F-19F0-4E58-86A8-5F1FFF43C661Q36328508-496ED27E-C857-467F-8178-651495DC74A7Q36547707-17F8E2A2-294A-4F4F-9042-5E9743B1A3A5Q36772529-13FD6EF6-9116-4733-8EFA-F702E35741A4Q36781867-064DF52F-B467-4815-B4C9-D26F09492FD9Q37119996-494A844E-3A33-47C8-AB10-212EA1619A61Q37132800-D486149B-60A0-4636-83AE-360BADCC284DQ37336885-AB4F4CE1-0DA2-4737-8865-12182F83AC6CQ37484011-B7BD9613-0FE7-429B-80B7-191AC79A4112Q37619180-F2CDD00F-D43D-4BB1-93FD-6E7E6FBDE402
P2860
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of proteins i ...... and tandem mass spectrometry.
@ast
Characterization of proteins i ...... and tandem mass spectrometry.
@en
type
label
Characterization of proteins i ...... and tandem mass spectrometry.
@ast
Characterization of proteins i ...... and tandem mass spectrometry.
@en
prefLabel
Characterization of proteins i ...... and tandem mass spectrometry.
@ast
Characterization of proteins i ...... and tandem mass spectrometry.
@en
P2093
P356
P1476
Characterization of proteins i ...... and tandem mass spectrometry.
@en
P2093
Anil K Rustgi
Ian A Blair
Kenneth H Yu
P304
P356
10.1021/PR050174L
P577
2005-09-01T00:00:00Z